Who we are

Genomac Holdings is headquartered in Ogbomoso,
Nigeria, with expansion to Lagos and planned operations
in Morocco. We orchestrate subsidiaries and flagship
initiatives in genomics, biotechnology, healthcare, and
innovation, ensuring resilience, well-being, and
sustainable impact.

We create long-term value by managing subsidiaries,
building strategic partnerships, and commercializing
solutions that improve lives across Africa and beyond.

“Forging a Sustainable Future Through Strategic Innovation and Investment in Africa and Beyond”

About

Our Vision and Mission

As Guiding our strategic direction and defining our purpose
in transforming Africa's biotechnology landscape.

vision icon

Vision

To be Africa's foremost innovation powerhouse, establishing a transformative platform of landmark achievements in genomics, biotechnology, and healthcare that sets the global standard for multidisciplinary excellence and impact.

mission icon

Mission

To strategically govern, invest in, and scale multidisciplinary companies that pioneer breakthrough innovations in education, healthcare, biotechnology, entrepreneurship, and technology—creating lasting value and driving sustainable development across Africa and beyond.

Founder & CEO

Oluwaseyi Olawale

A visionary bioinformatician and innovator with expertise in genomics, metagenomics, transcriptomics, proteomics, and artificial intelligence. Oluwaseyi has empowered over 100,000 scientists across 100+ countries through Genomac Institute's educational programs.

Under his leadership, Genomac Holdings has spearheaded natural product research and development for diabetes, hemorrhoids, digestive health, and more, while building a diversified portfolio of subsidiaries that are transforming healthcare and biotechnology across Africa.

GenomicsBioinformaticsAI & Machine LearningNatural Product R&D
Founder

Our Journey

Key milestones in building Africa's biotechnology future

2022

Foundation

Founded with one laptop; began training scientists globally in genomics and bioinformatics.

2023

Subsidiary Framework

Consolidated subsidiary structure and international expansion of Genomac Institute.

2024

Flagship Initiatives

Formalized Omicsboard, AMRwatch Africa, and Ideaspora as flagship initiatives.

2025

Geographic Expansion

Lagos branch rollout for precision medicine; Morocco node planning for North Africa.

View Tour Site